BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37551386)

  • 1.
    Mashayekhi-Sardoo H; Rezaee R; Karimi G
    Asian Biomed (Res Rev News); 2020 Aug; 14(4):127-137. PubMed ID: 37551386
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review.
    Gholamnezhad Z; Havakhah S; Boskabady MH
    J Ethnopharmacol; 2016 Aug; 190():372-86. PubMed ID: 27364039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation on LD50 and subacute hepatic toxicity of Nigella sativa seed extracts in mice.
    Vahdati-Mashhadian N; Rakhshandeh H; Omidi A
    Pharmazie; 2005 Jul; 60(7):544-7. PubMed ID: 16076084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone.
    Tavakkoli A; Mahdian V; Razavi BM; Hosseinzadeh H
    J Pharmacopuncture; 2017 Sep; 20(3):179-193. PubMed ID: 30087794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antifungal activities of the essential oil and various extracts of Nigella sativa and its main component, thymoquinone against pathogenic dermatophyte strains.
    Mahmoudvand H; Sepahvand A; Jahanbakhsh S; Ezatpour B; Ayatollahi Mousavi SA
    J Mycol Med; 2014 Dec; 24(4):e155-61. PubMed ID: 25442918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glance at black cumin (
    Oskouei Z; Akaberi M; Hosseinzadeh H
    Iran J Basic Med Sci; 2018 Dec; 21(12):1200-1209. PubMed ID: 30627362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): a complementary drug with historical and clinical significance.
    Dajani EZ; Shahwan TG; Dajani NE
    J Physiol Pharmacol; 2016 Dec; 67(6):801-817. PubMed ID: 28195061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volatile compounds of black cumin (
    Kabir Y; Akasaka-Hashimoto Y; Kubota K; Komai M
    Heliyon; 2020 Oct; 6(10):e05343. PubMed ID: 33163654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of primary and specialized metabolites in Nigella sativa seeds, a spice with vast traditional and historical uses.
    Botnick I; Xue W; Bar E; Ibdah M; Schwartz A; Joel DM; Lev E; Fait A; Lewinsohn E
    Molecules; 2012 Aug; 17(9):10159-77. PubMed ID: 22922285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular benefits of black cumin (Nigella sativa).
    Shabana A; El-Menyar A; Asim M; Al-Azzeh H; Al Thani H
    Cardiovasc Toxicol; 2013 Mar; 13(1):9-21. PubMed ID: 22911452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and long term modulation of tissue minerals concentrations following oral administration of black cumin (Nigella sativa L.) seed oil to laboratory rats.
    Basheer I; Qureshi IZ
    Phytomedicine; 2018 Jan; 39():56-65. PubMed ID: 29433684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activity of Nigella sativa (black seed) - a review.
    Randhawa MA; Alghamdi MS
    Am J Chin Med; 2011; 39(6):1075-91. PubMed ID: 22083982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and experimental effects of
    Gholamnezhad Z; Shakeri F; Saadat S; Ghorani V; Boskabady MH
    Avicenna J Phytomed; 2019; 9(3):195-212. PubMed ID: 31143688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterization of a γ-terpinene synthase in Nigella sativa L (black cumin).
    Elyasi R; Majdi M; Krause ST; Kücükay N; Azizi A; Degenhardt J
    Phytochemistry; 2022 Oct; 202():113290. PubMed ID: 35803303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and toxicological properties of Nigella sativa.
    Ali BH; Blunden G
    Phytother Res; 2003 Apr; 17(4):299-305. PubMed ID: 12722128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemistry, pharmacology, and therapeutic uses of black seed (Nigella sativa).
    Kooti W; Hasanzadeh-Noohi Z; Sharafi-Ahvazi N; Asadi-Samani M; Ashtary-Larky D
    Chin J Nat Med; 2016 Oct; 14(10):732-745. PubMed ID: 28236403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review.
    H U; S M; A A; Pk M; R K; R D; D S; Aa M; Panda PK
    Recent Adv Antiinfect Drug Discov; 2023 Feb; ():. PubMed ID: 36815641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review on the Potential Therapeutic Roles of
    Mollazadeh H; Afshari AR; Hosseinzadeh H
    J Pharmacopuncture; 2017 Sep; 20(3):158-172. PubMed ID: 30087792
    [No Abstract]   [Full Text] [Related]  

  • 19. The Emergence of N. sativa L. as a Green Antifungal Agent.
    Pandey R; Pandey B; Bhargava A
    Mini Rev Med Chem; 2024 Feb; ():. PubMed ID: 38409693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review.
    Sadeghi E; Imenshahidi M; Hosseinzadeh H
    Mol Biol Rep; 2023 Jun; 50(6):5439-5454. PubMed ID: 37155017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.